Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Zymeworks Inc
(NY:
ZYME
)
6.430
UNCHANGED
Last Price
Updated: 7:00 PM EST, Dec 15, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Zymeworks Inc
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
5 Value Stocks In The Healthcare Sector
May 29, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About Zymeworks
May 18, 2023
Via
Benzinga
Zymeworks Announces Departure of Neil Klompas, President and Chief Operating Officer
May 18, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Top 5 Health Care Stocks That May Collapse In Q2
May 10, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Zymeworks Provides Corporate Update and Reports First Quarter 2023 Financial Results
May 08, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Overview Of Value Stocks In The Healthcare Sector
April 10, 2023
Via
Benzinga
What 7 Analyst Ratings Have To Say About Zymeworks
March 31, 2023
Via
Benzinga
Daiichi, Zymeworks Terminate Seven Year-Cancer Antibody Pact
March 20, 2023
Via
Benzinga
Earnings Scheduled For May 8, 2023
May 08, 2023
Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 per share on revenue of $462.26 million.
Via
Benzinga
Zymeworks Announces Participation in Upcoming Investor Conferences
May 01, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Presents New Data from Multiple Preclinical and Clinical Development Programs at the 2023 American Association for Cancer Research Annual Meeting
April 18, 2023
From
Zymeworks Inc.
Via
GlobeNewswire
Analyst Ratings for Zymeworks
March 08, 2023
Via
Benzinga
Earnings Preview: Zymeworks
March 06, 2023
Via
Benzinga
$3M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
January 24, 2023
Although US stocks closed higher on Monday, there were a few notable insider trades.
Via
Benzinga
The 7 Most Undervalued Stocks You Need to Know About
April 18, 2023
Given the risks targeting highly popular trades right now, the most undervalued stocks to buy may offer greater mileage.
Via
InvestorPlace
Zymeworks To Host First Quarter 2023 Results Conference Call
April 17, 2023
From
Zymeworks Inc.
Via
Business Wire
Zymeworks Announces Appointment of Derek J. Miller to its Board of Directors
April 10, 2023
From
Zymeworks Inc.
Via
Business Wire
Zymeworks Announces Participation in Upcoming Investor Conferences
April 03, 2023
From
Zymeworks Inc.
Via
Business Wire
Analyst Ratings for Zymeworks BC
January 20, 2023
Via
Benzinga
Zymeworks to Present Updated Data on Multiple Product Candidates at the American Association for Cancer Research (AACR) Annual Meeting
March 14, 2023
From
Zymeworks Inc.
Via
Business Wire
Zymeworks Offers Hope for More than Just Long-Term Investors
March 09, 2023
Zymeworks stock is up nearly 5% since reporting earnings and a rally that has put ZYME stock over 25% in the last 12 months and could send the stock higher
Via
MarketBeat
Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
March 08, 2023
Gainers Fresh Tracks Therapeutics, Inc. (NASDAQ: FRTX) rose 51.1% to $2.66 in pre-market trading after the company disclosed topline results from single and multiple ascending dose parts of Phase 1...
Via
Benzinga
Zymeworks Reports Fourth Quarter and Full Year 2022 Financial Results
March 07, 2023
From
Zymeworks Inc.
Via
Business Wire
Zymeworks Announces Participation in Upcoming Investor Conferences
February 28, 2023
From
Zymeworks Inc.
Via
Business Wire
Zymeworks To Host Fourth Quarter And Full Year 2022 Results Conference Call
February 21, 2023
From
Zymeworks Inc.
Via
Business Wire
Zymeworks Announces Participation in Upcoming Investor Conferences
January 25, 2023
From
Zymeworks Inc.
Via
Business Wire
Jazz Pharma, Zymeworks Highlight 84% Overall Survival At 18 Months From Zanidatamab In Esophageal Cancer
January 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 19, 2023
Via
Benzinga
Why Starbox Group Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
January 19, 2023
Gainers Tricida, Inc. (NASDAQ: TCDA) rose 37.7% to $0.1898 in pre-market trading after gaining 4% on Wednesday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
January 19, 2023
We're starting off Thursday with an overview of the biggest pre-market stock movers traders will want to keep an eye on!
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.